ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $10,100,000 | +287.6% | 535,498 | +132.1% | 0.00% | +100.0% |
| Q2 2019 | $2,606,000 | -20.6% | 230,739 | -4.1% | 0.00% | 0.0% |
| Q1 2019 | $3,284,000 | +25.1% | 240,567 | -6.1% | 0.00% | 0.0% |
| Q4 2018 | $2,626,000 | -41.7% | 256,140 | -5.3% | 0.00% | 0.0% |
| Q3 2018 | $4,502,000 | -3.9% | 270,372 | -8.8% | 0.00% | 0.0% |
| Q2 2018 | $4,683,000 | +5.4% | 296,437 | -15.2% | 0.00% | 0.0% |
| Q1 2018 | $4,441,000 | -7.8% | 349,641 | -16.9% | 0.00% | 0.0% |
| Q4 2017 | $4,816,000 | +0.2% | 420,605 | +0.2% | 0.00% | 0.0% |
| Q3 2017 | $4,806,000 | +78.2% | 419,700 | +78.1% | 0.00% | 0.0% |
| Q2 2017 | $2,697,000 | +1640.0% | 235,603 | +3084.7% | 0.00% | – |
| Q1 2017 | $155,000 | -86.0% | 7,398 | -86.1% | 0.00% | – |
| Q4 2016 | $1,109,000 | +3477.4% | 53,354 | +5504.4% | 0.00% | – |
| Q3 2016 | $31,000 | -99.6% | 952 | -99.7% | 0.00% | -100.0% |
| Q2 2016 | $8,636,000 | +0.9% | 345,821 | -1.0% | 0.00% | 0.0% |
| Q1 2016 | $8,559,000 | -17.4% | 349,482 | +11.4% | 0.00% | -33.3% |
| Q4 2015 | $10,358,000 | +41.2% | 313,599 | +40.1% | 0.00% | +50.0% |
| Q3 2015 | $7,335,000 | – | 223,918 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |